FUNDAMENTALS · Fundamentals · HK Consumer Defensive

Yantai North Andre Juice (2218) Fundamentals 2026 — P/E 52.5x, Revenue Analysis | SniperIQ

Yantai North Andre Juice (2218) is a HK-listed Consumer Defensive company in Beverages - Non-Alcoholic with a market capitalization of HK

3.6B, trading at HK
5.13 on the HKSE. This SniperIQ fundamentals page covers Yantai North Andre Juice's valuation (P/E 52.5x, P/B 5.7x), profitability (net margin 20.1%), revenue (¥1.7B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapHK
3.6B
P/E (TTM)52.5x
Net Margin20.1%
Revenue (FY25)¥1.7B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Yantai North Andre Juice's market cap?

Yantai North Andre Juice (2218) has a market capitalization of approximately HK

3.6B, trading at HK
5.13 on the HKSE. Market cap moves with the live share price.

What is Yantai North Andre Juice's P/E ratio?

Yantai North Andre Juice's trailing twelve-month P/E ratio is 52.5x, with a price-to-book (P/B) of 5.7x. Valuation multiples are best compared with Consumer Defensive sector peers rather than read in isolation.

How profitable is Yantai North Andre Juice?

Yantai North Andre Juice runs a net profit margin of 20.1%, a gross margin of 25.6%, and an operating margin of 20.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Yantai North Andre Juice generate?

Yantai North Andre Juice reported revenue of ¥1.7B for fiscal year 2025, with net income of ¥330M and earnings per share (EPS) of 0.96. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Yantai North Andre Juice pay a dividend?

Yantai North Andre Juice offers a trailing dividend yield of about 0.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Yantai North Andre Juice financially healthy?

Yantai North Andre Juice carries a debt-to-equity ratio of 0.00x and a current ratio of 17.81x, with a market beta of 0.20. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Yantai North Andre Juice a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Yantai North Andre Juice (2218) the key facts are: market cap HK

3.6B, P/E 52.5x, revenue ¥1.7B, 52-week range 12.91-41.14. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Defensive peers and form your own view.

Track Yantai North Andre Juice's full fundamentals live

Get Yantai North Andre Juice's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Hormel Foods (HRL) fundamentals · Daisho (2816) fundamentals · Ichimasa Kamaboko (2904) fundamentals · Sichuan Swellfun (600779) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons